During the peer-review process the editor and reviewers write an eLife assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) ...

ALISO VIEJO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced the appointment of Anand Sundaram as the company’s Vice President, Head ...

Use a spyglass and trapdoor to see caves & other hidden details beneath your Minecraft world! Explore secret bases & avoid hostile mobs. Trump's approval rating plunges with Republicans on key issue ...

SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its intraocular lens (IOL). Proceeds from the round, announced at the beginning of June, ...

All patients achieved 20/30 or better best corrected distance visual acuity (BCDVA) Significant IOP reduction at 18 months was also demonstrated with 100% of patients off all topical IOP-lowering ...

PEBBLE BEACH, Calif. -- It took only six holes for Rory McIlroy to make a splash in his season debut on the PGA Tour. Playing in Thursday's first round of the AT&T Pebble Beach Pro-Am, McIlroy aced ...

First off, to anyone who followed me on Ludvig Åberg this week … an apology. I was banking on the young Swede being over his illness from Torrey Pines and I couldn’t have been more wrong. As painful ...

Please provide your email address to receive an email when new articles are posted on . SpyGlass Pharma has completed enrollment in its phase 1/2 clinical trial evaluating a long-term drug delivery ...

SpyGlass prepares for End of Phase II meeting with the FDA to advance its Drug Delivery Platform into Phase III pivotal studies Innovative platform has the potential to enable all cataract surgeons to ...

The toughest of the three sites in Pebble’s celebrity pro-am rota, this imposing design plays like two courses in one. After plunging toward the ocean on its opening par 5, the routing romps through ...

SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three years. Last month, the Aliso Viejo-based eye-focused drug developer ...